Federal contract award
15B20525P00000049
NATIONAL DRUG CODE: 66215-0602-06 GENERIC NAME: SELEXIPAG 200MCG TAB TRADE NAME: UPTRAVI 200MCG TAB VA CLASS: CARDIOVASCULAR AGENTS,OTHER EVALUATION FACTOR: LOWEST PRICE TECHNICALLY ACCEPTABLE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Justice |
| Office | FMC DEVENS |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $43.9K |
| Current contract value | $43.9K |
| Potential contract value / ceiling | $43.9K |
| Start date | Apr 1, 2025 |
| Current end date | Apr 30, 2025 |
| Potential end date | Apr 30, 2025 |
| Latest award activity | Apr 15, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 15, 2025 | 0 | $43.9K | NATIONAL DRUG CODE: 66215-0602-06 GENERIC NAME: SELEXIPAG 200MCG TAB TRADE NAME: UPTRAVI 200MCG TAB VA CLASS: CARDIOVASCULAR AGENTS,OTHER EVALUATION FACTOR: LOWEST PRICE TECHNICALLY ACCEPTABLE |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.